Analytical Data
-
Gene name
TGFB1
- Application
-
Alternative Names
TGFB1；TGFB；Transforming growth factor beta-1 proProtein
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
P01137
-
Expression Region
279-390aa
-
AA Sequence
ALDTNYCFSS TEKNCCVRQL YIDFRKDLGW KWIHEPKGYH ANFCLGPCPY IWSLDTQYSK VLALYNQHNP GASAAPCCVP QALEPLPIVY YVGRKPKVEQ LSNMIVRSCK CS
-
Molecular Weight
25 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
Transforming Growth Factor Beta 1 (TGFB1) is a multifunctional cytokine that plays a critical role in cell proliferation, differentiation, and immune regulation. Dysregulation of TGFB1 has been implicated in various pathological conditions, including fibrosis, cancer, and autoimmune diseases. Research into recombinant TGFB1 proteins aims to enhance our understanding of its biological functions and therapeutic potential. Advances in recombinant DNA technology allow for the production of high-purity TGFB1, facilitating detailed studies of its signaling pathways and interactions with other cellular components. Furthermore, TGFB1's pivotal role in tissue repair and regeneration has led to investigations into its application in regenerative medicine, particularly in wound healing and tissue engineering. By exploring the mechanisms through which TGFB1 operates, researchers hope to identify novel therapeutic targets and develop strategies to modulate its activity for better clinical outcomes. Overall, the study of recombinant TGFB1 is essential for unraveling its complex biology and harnessing its potential for treating various diseases.
